0001127602-14-010261.txt : 20140305
0001127602-14-010261.hdr.sgml : 20140305
20140305161738
ACCESSION NUMBER: 0001127602-14-010261
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140301
FILED AS OF DATE: 20140305
DATE AS OF CHANGE: 20140305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSULET CORP
CENTRAL INDEX KEY: 0001145197
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 OAK PARK DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-5000
MAIL ADDRESS:
STREET 1: 9 OAK PARK DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LIAMOS CHARLES T
CENTRAL INDEX KEY: 0001181286
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33462
FILM NUMBER: 14669471
MAIL ADDRESS:
STREET 1: 1360 SOUTH LOOP ROAD
CITY: ALAMEDA
STATE: CA
ZIP: 94502
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-03-01
0001145197
INSULET CORP
PODD
0001181286
LIAMOS CHARLES T
C/O INSULET CORPORATION
9 OAK PARK DRIVE
BEDFORD
MA
01730
1
Common Stock
2014-03-01
4
A
0
33000
0
A
110316
D
Common Stock
2014-03-01
4
F
0
9482
47.41
D
100834
D
Common Stock
2014-03-03
4
M
0
10000
15.82
A
110834
D
Common Stock
2014-03-03
4
S
0
10000
45.8465
D
100834
D
Employee Stock Option (Right to Buy)
15.82
2014-03-03
4
M
0
10000
0
D
2021-01-10
Common Stock
10000
50000
D
The 33,000 performance share units were granted on March 1, 2013, and the Compensation Committee of the Board of Directors subsequently determined the performance share units were earned based on the performance of the Company. 11,000 performance share units vested on March 1, 2014, and the remaining 22,000 performance share units vest one-half of the total units on March 1, 2015 and one-half of the total units on March 1, 2016. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
Includes 24,000 restricted stock units granted on April 1, 2012, which vest one-third of the total units on April 1, 2014, one-third of the total units on April 1, 2015 and one-third of the total units on April 1, 2016; and 22,500 restricted stock units granted on March 1, 2013, which vest one-third of the total units on March 1, 2015, one-third of the total units on March 1, 2016 and one-third of the total units on March 1, 2017. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
Includes an aggregate of 1,166 shares acquired under the Insulet Corporation Amended and Restated 2007 Employee Stock Purchase Plan on the following dates: 357 shares acquired on June 29, 2012; 360 shares acquired on December 31, 2012; 243 shares acquired on June 28, 2013; and 206 shares acquired on December 31, 2013.
This transaction represents the withholding of shares received upon the vesting of restricted stock units and performance share units to cover the associated tax obligations.
Includes 24,000 restricted stock units granted on April 1, 2012, which vest one-third of the total units on April 1, 2014, one-third of the total units on April 1, 2015 and one-third of the total units on April 1, 2016; 22,500 restricted stock units granted on March 1, 2013, which vest one-third of the total units on March 1, 2015, one-third of the total units on March 1, 2016 and one-third of the total units on March 1, 2017; and 22,000 performance share units granted on March 1, 2013, which vest one-half of the total units on March 1, 2015 and one-half of the total units on March 1, 2016. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2013.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $45.06 to $46.78. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full informaiton regarding the number of shares sold at each separate price.
This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
/s/ R. Anthony Diehl, attorney in fact
2014-03-04